Clinical efficacy of vedolizumab for inflammatory bowel disease

Liu Sixue; Zhong Wa; Lin Ying; Xia Zhongsheng; Zhong Yingqiang

doi:10.3969/j.issn.0253-9802.2022.10.012

Liu Sixue, Zhong Wa, Lin Ying, Xia Zhongsheng, Zhong Yingqiang

JOURNAL OF NEW MEDICINE ›› 2022, Vol. 53 ›› Issue (10) : 767-773.

PDF(842 KB)

JOURNAL OF NEW MEDICINE ›› 2022, Vol. 53 ›› Issue (10) : 767-773. DOI: 10.3969/j.issn.0253-9802.2022.10.012

Original Research

Clinical efficacy of vedolizumab for inflammatory bowel disease

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 53(10): 767-773 https://doi.org/10.3969/j.issn.0253-9802.2022.10.012

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(842 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-06-25	2022-10-15
Issue Date
2022-11-06

Please choose a citation manager

Content to export